This toll on our states health is also a toll on our economy, costing an estimated $10.7 billion a year, or nearly 2% of GDP
Stopping and restarting GLP-1 medications can actually cause more digestive distress than staying the course
For those with pre-existing kidney disease, particularly an eGFR below 45 mL/min/1.73m2, consult a nephrologist before starting creatine
THIS PACKAGE INCLUDES THE TOP 3 PRODUCTS USED FOR WEIGHT LOSS #1 B12 INJECTIONS: You get 10 Injections and supplies
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity - Article Summary Virginia Journal of Medicine Oct 5, 2025 3 min read Summary Author: Maximillian Brune Brief Summary: Tirzepatide and semaglutide are both part of a new generation of drugs for the treatment of obesity
Reports of employers and insurers canceling coverage could help drive prices lower, as could entry by a third pharmaceutical company